Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Opertech Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
Opertech Bio

Opertech Bio

Pre-Seed

Opertech Bio: Revolutionizing taste testing for the food, beverage, and pharmaceutical industries.

HQ
Philadelphia, PA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Opertech Bio, founded with the mission to revolutionize taste testing, focuses on the food and beverage, flavor ingredients, pet food, and pharmaceutical industries. The company offers innovative services and technologies for measuring taste, aiming to transform how these industries develop and refine their products. By providing a pioneering approach to taste testing, Opertech Bio addresses a multi-billion dollar market, enhancing product development efficiency and accuracy.

Notable figures associated with Opertech Bio include a team of experienced professionals and consultants who bring extensive expertise to the company. Opertech Bio's key achievements include the successful implementation of their unique taste-testing methodologies, which have significantly impacted product development processes across various industries. Their contributions have led to enhanced product quality and consumer satisfaction, establishing Opertech Bio as a leader in the taste-testing market.

Opertech Bio - Quick Facts

When was Opertech Bio founded?

Opertech Bio was founded in 2011.

Where is Opertech Bio's headquarters located?

Opertech Bio's headquarters is located in Philadelphia, PA, US.

When was Opertech Bio's last funding round?

Opertech Bio's most recent funding round was for $750k (USD) in December 2014.

How much has Opertech Bio raised to-date?

As of Dec 22, 2014, Opertech Bio has raised a total of $750k (USD).

How many employees does Opertech Bio have?

Opertech Bio has 8 employees as of Feb 4, 2024.

Opertech Bio - Classification

Industry
  • Professional Service Companies
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Taste Testing
Tags
  • Consulting
NAICS
  • 310000Manufacturing
  • 311000Food Manufacturing
SIC
  • 2000Food And Kindred Products
Show 4 more industry codes
NAICS
  • 311100Animal Food Manufacturing
  • 311110Animal Food Manufacturing
SIC
  • 2040Grain Mill Products
  • 2048Prepared Feeds And Feed Ingredients For Animals And Fowls, Except Dog And Cat